Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
ISI - Improving Diagnosis of Severe Infections in Immunocompromised Patients
- Overall study
- Study Sites (1)
Köln
Klinik I für Innere Medizin
Postal Address
Kerpener Str. 62
50937 Köln, Germany
Visitor Address
Kerpener Str. 62
50937 Köln, Germany
Study office
DZIF-CTU Köln
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Status
Active
Principal Investigator
Univ.-Prof. Dr. med. Oliver A. Cornely
Contact at Site
- Dr. rer. medic. Dipl.-Biochem. Fedja Farowski
- Tel. +49 221 478-6494 / -6209
- Fax +49 221 478-3611 / -86696
- fedja.farowski@ctuc.de
- Univ.-Prof. Dr. med. Jörg Janne Vehreschild
- Tel. +49 (0)221 478-88794 / +49 171 6211442
- Fax +49 (0)221 478-85504
- janne.vehreschild@uk-koeln.de